• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CD4/CD8 imbalance as a key factor in the progression from mogamulizumab-induced drug eruption to adult T-cell leukemia/lymphoma.

作者信息

Inayoshi Sakiho, Inoue Takuya, Sugita Kazunari

机构信息

Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.

出版信息

JAAD Case Rep. 2025 Jun 10;63:19-23. doi: 10.1016/j.jdcr.2025.05.011. eCollection 2025 Sep.

DOI:10.1016/j.jdcr.2025.05.011
PMID:40787045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12328758/
Abstract
摘要

相似文献

1
CD4/CD8 imbalance as a key factor in the progression from mogamulizumab-induced drug eruption to adult T-cell leukemia/lymphoma.CD4/CD8失衡是从莫加莫拉单抗诱导的药疹进展为成人T细胞白血病/淋巴瘤的关键因素。
JAAD Case Rep. 2025 Jun 10;63:19-23. doi: 10.1016/j.jdcr.2025.05.011. eCollection 2025 Sep.
2
Evaluating mogamulizumab in the treatment of primary cutaneous T-cell lymphoma.评估莫加莫拉单抗治疗原发性皮肤T细胞淋巴瘤的疗效。
Immunotherapy. 2025 Jun;17(8):551-559. doi: 10.1080/1750743X.2025.2520153. Epub 2025 Jun 24.
3
Exploratory Analysis of Practical Predictive Indices for the Efficacy of Mogamulizumab in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma.莫加莫拉单抗治疗侵袭性成人T细胞白血病-淋巴瘤患者疗效的实用预测指标的探索性分析
Hematol Oncol. 2025 Jul;43(4):e70114. doi: 10.1002/hon.70114.
4
Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world database.利用真实世界数据库进行的用于识别莫加莫拉单抗诱导的免疫相关不良事件的药物警戒研究。
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf201.
5
Structural Insights into the ADCC Mechanism and Resistance of Mogamulizumab, a First-in-Class Anti-CCR4 Therapy for Cutaneous T Cell Lymphoma.对莫加莫拉单抗（一种用于皮肤T细胞淋巴瘤的一流抗CCR4疗法）的ADCC机制及耐药性的结构洞察。
Int J Mol Sci. 2025 Jun 8;26(12):5500. doi: 10.3390/ijms26125500.
6
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies.一项关于白细胞介素-15联合莫格利珠单抗治疗复发难治性T细胞恶性肿瘤的1期研究。
Blood Neoplasia. 2024 Nov 2;2(1):100054. doi: 10.1016/j.bneo.2024.100054. eCollection 2025 Feb.
7
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.莫格利珠单抗治疗既往治疗的蕈样真菌病和塞扎里综合征：NICE 单一技术评估的证据审查小组观点。
Pharmacoeconomics. 2022 May;40(5):509-518. doi: 10.1007/s40273-021-01098-3. Epub 2021 Oct 19.
8
Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma.莫格利珠单抗治疗成人 T 细胞白血病/淋巴瘤患者后，CD8+ T 细胞增殖和多样化增强。
Blood Adv. 2020 May 26;4(10):2180-2191. doi: 10.1182/bloodadvances.2020001641.
9
Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas.莫格利珠单抗：一种用于 T 细胞淋巴瘤的抗 CC 趋化因子受体 4 抗体。
Ann Pharmacother. 2020 Apr;54(4):371-379. doi: 10.1177/1060028019884863. Epub 2019 Oct 25.
10
Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.莫加莫珠单抗治疗成人T细胞白血病-淋巴瘤：一项多中心前瞻性观察研究。
Blood Adv. 2020 Oct 27;4(20):5133-5145. doi: 10.1182/bloodadvances.2020003053.

本文引用的文献

1
Adult T-cell leukemia/lymphoma clinically confused with viral/drug skin eruptions and pathologically misinterpreted as mycosis fungoides/Sézary syndrome.成人T细胞白血病/淋巴瘤在临床上易与病毒/药物性皮肤疹相混淆，在病理上易被误诊为蕈样肉芽肿/赛塞里综合征。
J Cutan Pathol. 2021 Sep;48(9):1103-1108. doi: 10.1111/cup.13789. Epub 2020 Dec 22.
2
A Rare CD4-CD8+ Adult T-Cell Leukemia/Lymphoma with Unique Molecular Mutations: A Case Report with Literature Review.一例具有独特分子突变的罕见CD4-CD8+成人T细胞白血病/淋巴瘤：病例报告及文献复习
Case Rep Hematol. 2020 Oct 30;2020:8890502. doi: 10.1155/2020/8890502. eCollection 2020.
3
CD8+ T-cell-mediated Interface Dermatitis after CCR4+ T-cell Depletion by Mogamulizumab Treatment of Adult T-cell Leukaemia/lymphoma.
莫加莫珠单抗治疗成人T细胞白血病/淋巴瘤导致CCR4 + T细胞耗竭后CD8 + T细胞介导的界面性皮炎
Acta Derm Venereol. 2017 Mar 10;97(3):377-378. doi: 10.2340/00015555-2555.
4
Late onset toxic epidermal necrolysis induced by mogamulizumab, an anti-CC chemokine receptor 4 antibody for the treatment of adult T-cell leukaemia/lymphoma.莫加莫拉单抗诱发的迟发性中毒性表皮坏死松解症，莫加莫拉单抗是一种用于治疗成人T细胞白血病/淋巴瘤的抗CC趋化因子受体4抗体。
Hematol Oncol. 2017 Mar;35(1):138-140. doi: 10.1002/hon.2242. Epub 2015 Jul 14.
5
Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia / lymphoma.Stevens-Johnson 综合征与莫格利珠单抗治疗成人 T 细胞白血病/淋巴瘤相关。
Cancer Sci. 2013 May;104(5):647-50. doi: 10.1111/cas.12116. Epub 2013 Mar 10.
6
Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma.皮疹类型是成人 T 细胞白血病/淋巴瘤的独立预后指标。
Blood. 2011 Apr 14;117(15):3961-7. doi: 10.1182/blood-2010-11-316794. Epub 2011 Feb 16.
7
Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).成人T细胞白血病-淋巴瘤临床亚型的诊断标准及分类。淋巴瘤研究组报告（1984 - 1987年）
Br J Haematol. 1991 Nov;79(3):428-37. doi: 10.1111/j.1365-2141.1991.tb08051.x.